Main Download report Dansk Novozymes.com
Print Print
Audited by PwC

Summary and key figures 2005-2001

DKK milion   2005  2004  2003  2002  2001   
Income statement
Net turnover 3,493  3,537  3,537  3,329  3,341 
EBITDA 872  1,374  870  805  890 
Operating profit 569  1,057  550  490  585 
Income before tax on participating interests in subsidiaries 609  33  422  448  323 
Financial items, net (32) (26) 49  (26) (32)
Profit before tax 1,146  1,064  1,021  912  876 
Net profit 857  779  736  655  607 
Balance sheet
Fixed assets 4,595  4,283  4,727  4,762  5,017 
Current assets 2,489  2,390  2,812  3,089  2,652 
Total assets 7,084  6,673  7,539  7,851  7,669 
Share capital 696  726  754  754  754 
Shareholders' equity 3,752  3,917  4,056  4,057  3,949 
Non-current liabilities 1,353  1,245  1,072  1,863  1,892 
Current liabilities 1,791  1,222  1,914  1,407  1,338 
Net interest-bearing debt 1,282  914  860  1,037  1,184 
Key figures
EBITDA margin % 25.0 38.8 24.6 24.2 26.6
Operating profit margin % 16.3 29.9 15.5 14.7 17.5
Net profit margin % 24.5 22.0 20.8 19.7 18.2
Equity ratio % 53.0 58.7 53.8 51.7 51.5
Return on equity % 22.3 19.5 18.1 16.4 15.6
ROIC including goodwill % 8.7 16.6 9.1 7.8 8.5
© Novozymes 2006 Krogshøjvej 36 - DK-2880 Bagsværd - +45 8824 9999 - info@novozymes.com Privacy | Legal | About The Novozymes Report